E. Baskin Et Al. , "Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study.," Journal of nephrology , vol.35, no.4, pp.1213-1222, 2022
Baskin, E. Et Al. 2022. Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study.. Journal of nephrology , vol.35, no.4 , 1213-1222.
Baskin, E., Fidan, K., GÜLHAN, B., Gulleroglu, K., CANPOLAT, N., Yilmaz, A., ... Parmakiz, G.(2022). Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study.. Journal of nephrology , vol.35, no.4, 1213-1222.
Baskin, Esra Et Al. "Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study.," Journal of nephrology , vol.35, no.4, 1213-1222, 2022
Baskin, Esra Et Al. "Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study.." Journal of nephrology , vol.35, no.4, pp.1213-1222, 2022
Baskin, E. Et Al. (2022) . "Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study.." Journal of nephrology , vol.35, no.4, pp.1213-1222.
@article{article, author={Esra Baskin Et Al. }, title={Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study.}, journal={Journal of nephrology}, year=2022, pages={1213-1222} }